All Intraosseous Sites are Not Equal.
Clinical Data Suggests the Sternal IO Route Improves Patient Outcomes
Download the new Clinical Review Paper compiled by Dr. Alan Moloff
In this new Clinical Review Paper, Dr. Alan Moloff reviews four independent clinical studies that suggest the Sternal IO route improves patient outcomes.
The studies reviewed indicate that the sternal approach for deploying IO may be more effective to get critical medications into the central circulation faster, and in higher concentrations, during cardiac arrest.
Direct quotes from the studies include*:
Study #1 - Hoskins, Stephen L, et al:
“Based on the present data, we recommend that sternal IO route be considered as the first choice of drug delivery during CPR when IV access has not been established…” (1)
Study #2 - Pasley, Jason, et al:
“...the sternal IO site provided the highest flow rates compared with the humeral and tibial insertion sites. The sternal site was also associated with a 100% success rate for initial placement facilitated by its consistent anatomy.” (2)
Study #3: Burgert, James, et al:
“There may also be a relationship between the anatomical location of the IO device and serum drug concentrations; the more distal the IO infusion site is from the sampling site, the longer concentrations of drug take to rise.” (3)
The quotes above are taken from three of the four important studies reviewed in the Clinical Review Paper by Dr. Alan Moloff . To download the full paper and access references (1), (2), and (3), fill out the form to the right.
Use the Form to the Right to Download the Clinical Review Paper Now.
* By filling in the form on this page, you give your Express Consent to receive electronic communication from Pyng Medical, including information and updates on our intraosseous infusion, pelvic stabilization and tourniquet devices. You can unsubscribe at any time by clicking "unsubscribe" at the bottom of any email you receive from Pyng Medical.